Hélène Labussière‐Wallet

2.5k total citations
72 papers, 683 citations indexed

About

Hélène Labussière‐Wallet is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Hélène Labussière‐Wallet has authored 72 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hematology, 20 papers in Public Health, Environmental and Occupational Health and 13 papers in Oncology. Recurrent topics in Hélène Labussière‐Wallet's work include Hematopoietic Stem Cell Transplantation (49 papers), Acute Myeloid Leukemia Research (44 papers) and Acute Lymphoblastic Leukemia research (20 papers). Hélène Labussière‐Wallet is often cited by papers focused on Hematopoietic Stem Cell Transplantation (49 papers), Acute Myeloid Leukemia Research (44 papers) and Acute Lymphoblastic Leukemia research (20 papers). Hélène Labussière‐Wallet collaborates with scholars based in France, Israel and Germany. Hélène Labussière‐Wallet's co-authors include Mohamad Mohty, Myriam Labopin, Arnon Nagler, Fiorenza Barraco, Gilles Salles, Xavier Thomas, Florence Ader, Sophie Ducastelle-Leprêtre, Gèrard Socié and Mauricette Michallet and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Cancer.

In The Last Decade

Hélène Labussière‐Wallet

65 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hélène Labussière‐Wallet France 15 452 249 190 88 86 72 683
Javier Anguita Spain 16 405 0.9× 177 0.7× 109 0.6× 122 1.4× 86 1.0× 65 688
Mary Sartor Australia 14 348 0.8× 184 0.7× 137 0.7× 241 2.7× 91 1.1× 36 737
Fiorenza Barraco France 15 373 0.8× 262 1.1× 45 0.2× 107 1.2× 121 1.4× 72 901
Heike Bialleck Germany 13 343 0.8× 212 0.9× 50 0.3× 171 1.9× 37 0.4× 16 643
Xiang‐Yu Zhao China 17 390 0.9× 278 1.1× 83 0.4× 189 2.1× 63 0.7× 69 747
Elke Dammann Germany 16 286 0.6× 161 0.6× 82 0.4× 204 2.3× 66 0.8× 36 555
Sabine Fürst France 20 843 1.9× 289 1.2× 254 1.3× 88 1.0× 66 0.8× 64 1.0k
Marcie Tomblyn United States 10 318 0.7× 194 0.8× 81 0.4× 164 1.9× 37 0.4× 21 551
Alice Garnier France 15 391 0.9× 220 0.9× 66 0.3× 45 0.5× 83 1.0× 73 653
Angéla Granata France 19 679 1.5× 300 1.2× 186 1.0× 105 1.2× 46 0.5× 61 863

Countries citing papers authored by Hélène Labussière‐Wallet

Since Specialization
Citations

This map shows the geographic impact of Hélène Labussière‐Wallet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Labussière‐Wallet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Labussière‐Wallet more than expected).

Fields of papers citing papers by Hélène Labussière‐Wallet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Labussière‐Wallet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Labussière‐Wallet. The network helps show where Hélène Labussière‐Wallet may publish in the future.

Co-authorship network of co-authors of Hélène Labussière‐Wallet

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Labussière‐Wallet. A scholar is included among the top collaborators of Hélène Labussière‐Wallet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Labussière‐Wallet. Hélène Labussière‐Wallet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dubois, Valérie, Marie Balsat, Sophie Ducastelle, et al.. (2025). HLA diversity is associated with TKI response and treatment‐free remission in chronic myeloid leukemia. HemaSphere. 9(11). e70261–e70261.
2.
Chevallier, Patrice, Anne C. M. Thiébaut, Sylvie François, et al.. (2025). A phase II study of ponatinib for prevention of relapse after allotransplantation in <i>FLT3</i> internal tandem duplication mutation positive (FLT3-ITD+) acute myeloid leukemia: the PONALLO trial. Haematologica. 110(10). 2525–2529. 1 indexed citations
3.
Xhaard, Aliénor, Constance Xhaard, Marie‐Thérèse Rubio, et al.. (2023). A 16‐month‐long experience of COVID‐19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM‐TC multicentre cohort study. British Journal of Haematology. 201(6). 1066–1071. 3 indexed citations
4.
5.
6.
Pleșa, Adriana, Gaëlle Fossard, Fiorenza Barraco, et al.. (2022). Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study. Transplantation and Cellular Therapy. 29(1). 38.e1–38.e9. 4 indexed citations
7.
Nagler, Arnon, Jacques‐Emmanuel Galimard, Myriam Labopin, et al.. (2022). Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT. Bone Marrow Transplantation. 57(12). 1788–1796. 5 indexed citations
8.
Loke, Justin, Myriam Labopin, Charles Craddock, et al.. (2022). Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia. Cancer. 128(15). 2922–2931. 31 indexed citations
9.
Mouton, William, Anne Conrad, Vincent Alcazer, et al.. (2022). Distinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(2). 94.e1–94.e13. 5 indexed citations
10.
11.
Dubois, Valérie, Hélène Labussière‐Wallet, Fabienne Venet, et al.. (2022). Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Frontiers in Immunology. 13. 841470–841470. 15 indexed citations
12.
Mikulska, Małgorzata, Olaf Penack, Nina Knelange, et al.. (2021). HEV infection in stem cell transplant recipients—retrospective study of EBMT Infectious Diseases Working Party. Bone Marrow Transplantation. 57(2). 167–175. 5 indexed citations
13.
14.
Giebel, Sebastian, Myriam Labopin, Gèrard Socié, et al.. (2020). Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplantation. 56(5). 1047–1055. 1 indexed citations
15.
Fatobene, Giancarlo, Fernanda Volt, Frederico Rafael Moreira, et al.. (2020). Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseases. Blood Advances. 4(24). 6327–6335. 7 indexed citations
16.
Sanz, Jaime, Myriam Labopin, Miguel Á. Sanz, et al.. (2020). Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission. Bone Marrow Transplantation. 56(6). 1272–1280. 22 indexed citations
17.
Labopin, Myriam, Gèrard Socié, Maija Itälä‐Remes, et al.. (2020). Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia. Blood Cancer Journal. 10(3). 26–26. 33 indexed citations
18.
Pleșa, Adriana, Hélène Labussière‐Wallet, Sandrine Hayette, et al.. (2019). Efficiency of blinatumomab in a t(8;21) acute myeloid leukemia expressing CD19. Haematologica. 104(10). e487–e488. 5 indexed citations
19.
Shem‐Tov, Noga, Christophe Peczynski, Myriam Labopin, et al.. (2019). Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT. Leukemia. 34(1). 283–292. 37 indexed citations
20.
Sheth, Vipul, Myriam Labopin, Jonathan Canaani, et al.. (2018). Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysis. Bone Marrow Transplantation. 54(4). 531–539. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Javier Anguita Breakdown of academic impact, for papers by Mary Sartor Breakdown of academic impact, for papers by Fiorenza Barraco Breakdown of academic impact, for papers by Heike Bialleck Breakdown of academic impact, for papers by Xiang‐Yu Zhao Breakdown of academic impact, for papers by Elke Dammann Breakdown of academic impact, for papers by Sabine Fürst Breakdown of academic impact, for papers by Marcie Tomblyn Breakdown of academic impact, for papers by Alice Garnier Breakdown of academic impact, for papers by Angéla Granata
Rankless by CCL
2026